Publication | Closed Access

Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults

VaccinationEp Hiv-1090Vaccine TargetHuman RetrovirusImmunologyVaccine DesignHivCytotoxic T-lymphocyte Poly-epitopeMedicinePolyvalent VaccineDna Plasmid